nodes	percent_of_prediction	percent_of_DWPC	metapath
Itraconazole—Urine analysis abnormal—Varenicline—nicotine dependence	0.0202	0.0296	CcSEcCtD
Itraconazole—Upset stomach—Varenicline—nicotine dependence	0.0181	0.0266	CcSEcCtD
Itraconazole—Electrocardiogram abnormal—Varenicline—nicotine dependence	0.0181	0.0266	CcSEcCtD
Itraconazole—Pharyngolaryngeal pain—Varenicline—nicotine dependence	0.0176	0.0258	CcSEcCtD
Itraconazole—CYP2B6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0175	0.0552	CbGpPWpGaD
Itraconazole—Menstrual disorder—Varenicline—nicotine dependence	0.0174	0.0256	CcSEcCtD
Itraconazole—Laryngeal pain—Varenicline—nicotine dependence	0.0174	0.0256	CcSEcCtD
Itraconazole—CYP2E1—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0172	0.054	CbGpPWpGaD
Itraconazole—Fungal infection—Varenicline—nicotine dependence	0.0154	0.0226	CcSEcCtD
Itraconazole—Gingivitis—Varenicline—nicotine dependence	0.0151	0.0222	CcSEcCtD
Itraconazole—CYP3A7—Xenobiotics—CYP2A7—nicotine dependence	0.0147	0.0463	CbGpPWpGaD
Itraconazole—Dysphonia—Varenicline—nicotine dependence	0.0144	0.0212	CcSEcCtD
Itraconazole—CYP2B6—Fatty acids—CYP2A7—nicotine dependence	0.0137	0.0431	CbGpPWpGaD
Itraconazole—CYP51A1—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.0136	0.0429	CbGpPWpGaD
Itraconazole—CYP51A1—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.0135	0.0424	CbGpPWpGaD
Itraconazole—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0122	0.0384	CbGpPWpGaD
Itraconazole—Hyperkalaemia—Varenicline—nicotine dependence	0.0117	0.0171	CcSEcCtD
Itraconazole—CYP51A1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.0111	0.0348	CbGpPWpGaD
Itraconazole—CYP2B6—Xenobiotics—CYP2A7—nicotine dependence	0.0109	0.0342	CbGpPWpGaD
Itraconazole—Mouth ulceration—Varenicline—nicotine dependence	0.0107	0.0157	CcSEcCtD
Itraconazole—CYP2E1—Xenobiotics—CYP2A7—nicotine dependence	0.0106	0.0335	CbGpPWpGaD
Itraconazole—CYP3A5—Xenobiotics—CYP2A7—nicotine dependence	0.0106	0.0334	CbGpPWpGaD
Itraconazole—CYP1A1—Xenobiotics—CYP2A7—nicotine dependence	0.01	0.0316	CbGpPWpGaD
Itraconazole—Deafness—Varenicline—nicotine dependence	0.00964	0.0141	CcSEcCtD
Itraconazole—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.00951	0.0299	CbGpPWpGaD
Itraconazole—Libido decreased—Varenicline—nicotine dependence	0.0093	0.0136	CcSEcCtD
Itraconazole—Hot flush—Varenicline—nicotine dependence	0.00922	0.0135	CcSEcCtD
Itraconazole—Increased appetite—Varenicline—nicotine dependence	0.00918	0.0135	CcSEcCtD
Itraconazole—Menopausal symptoms—Varenicline—nicotine dependence	0.00914	0.0134	CcSEcCtD
Itraconazole—Visual disturbance—Varenicline—nicotine dependence	0.0091	0.0133	CcSEcCtD
Itraconazole—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.00856	0.0125	CcSEcCtD
Itraconazole—Liver function test abnormal—Varenicline—nicotine dependence	0.00796	0.0117	CcSEcCtD
Itraconazole—Abdominal pain upper—Varenicline—nicotine dependence	0.00788	0.0115	CcSEcCtD
Itraconazole—Hypokalaemia—Varenicline—nicotine dependence	0.00785	0.0115	CcSEcCtD
Itraconazole—Breast disorder—Varenicline—nicotine dependence	0.0078	0.0114	CcSEcCtD
Itraconazole—Gastritis—Varenicline—nicotine dependence	0.00763	0.0112	CcSEcCtD
Itraconazole—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.00755	0.0238	CbGpPWpGaD
Itraconazole—Abdominal distension—Varenicline—nicotine dependence	0.00751	0.011	CcSEcCtD
Itraconazole—Dysphagia—Varenicline—nicotine dependence	0.00746	0.0109	CcSEcCtD
Itraconazole—Bronchitis—Varenicline—nicotine dependence	0.00717	0.0105	CcSEcCtD
Itraconazole—Abdominal discomfort—Varenicline—nicotine dependence	0.00715	0.0105	CcSEcCtD
Itraconazole—Pollakiuria—Varenicline—nicotine dependence	0.00689	0.0101	CcSEcCtD
Itraconazole—Erectile dysfunction—Varenicline—nicotine dependence	0.00687	0.0101	CcSEcCtD
Itraconazole—Photosensitivity reaction—Varenicline—nicotine dependence	0.00681	0.00997	CcSEcCtD
Itraconazole—Hyperglycaemia—Varenicline—nicotine dependence	0.00673	0.00986	CcSEcCtD
Itraconazole—Infestation—Varenicline—nicotine dependence	0.00665	0.00974	CcSEcCtD
Itraconazole—Infestation NOS—Varenicline—nicotine dependence	0.00665	0.00974	CcSEcCtD
Itraconazole—Depression—Varenicline—nicotine dependence	0.00663	0.00972	CcSEcCtD
Itraconazole—Stevens-Johnson syndrome—Varenicline—nicotine dependence	0.00659	0.00966	CcSEcCtD
Itraconazole—Hepatobiliary disease—Varenicline—nicotine dependence	0.00629	0.00921	CcSEcCtD
Itraconazole—Sinusitis—Varenicline—nicotine dependence	0.00624	0.00914	CcSEcCtD
Itraconazole—CYP51A1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00623	0.0196	CbGpPWpGaD
Itraconazole—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.0061	0.0192	CbGpPWpGaD
Itraconazole—CYP3A7—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00602	0.019	CbGpPWpGaD
Itraconazole—Hypoaesthesia—Varenicline—nicotine dependence	0.00594	0.0087	CcSEcCtD
Itraconazole—Urinary tract disorder—Varenicline—nicotine dependence	0.00589	0.00864	CcSEcCtD
Itraconazole—Oedema peripheral—Varenicline—nicotine dependence	0.00588	0.00862	CcSEcCtD
Itraconazole—CYP51A1—Biological oxidations—CYP2A7—nicotine dependence	0.00587	0.0185	CbGpPWpGaD
Itraconazole—Connective tissue disorder—Varenicline—nicotine dependence	0.00586	0.00859	CcSEcCtD
Itraconazole—Urethral disorder—Varenicline—nicotine dependence	0.00585	0.00857	CcSEcCtD
Itraconazole—CYP51A1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00579	0.0182	CbGpPWpGaD
Itraconazole—Visual impairment—Varenicline—nicotine dependence	0.00575	0.00843	CcSEcCtD
Itraconazole—Erythema multiforme—Varenicline—nicotine dependence	0.00564	0.00827	CcSEcCtD
Itraconazole—Eye disorder—Varenicline—nicotine dependence	0.00558	0.00817	CcSEcCtD
Itraconazole—Tinnitus—Varenicline—nicotine dependence	0.00556	0.00815	CcSEcCtD
Itraconazole—Cardiac disorder—Varenicline—nicotine dependence	0.00554	0.00812	CcSEcCtD
Itraconazole—Angiopathy—Varenicline—nicotine dependence	0.00541	0.00794	CcSEcCtD
Itraconazole—Immune system disorder—Varenicline—nicotine dependence	0.00539	0.0079	CcSEcCtD
Itraconazole—Mediastinal disorder—Varenicline—nicotine dependence	0.00538	0.00788	CcSEcCtD
Itraconazole—Chills—Varenicline—nicotine dependence	0.00535	0.00785	CcSEcCtD
Itraconazole—Arrhythmia—Varenicline—nicotine dependence	0.00533	0.00781	CcSEcCtD
Itraconazole—Mental disorder—Varenicline—nicotine dependence	0.00523	0.00766	CcSEcCtD
Itraconazole—Malnutrition—Varenicline—nicotine dependence	0.00519	0.00761	CcSEcCtD
Itraconazole—Flatulence—Varenicline—nicotine dependence	0.00512	0.0075	CcSEcCtD
Itraconazole—Dysgeusia—Varenicline—nicotine dependence	0.00509	0.00746	CcSEcCtD
Itraconazole—Back pain—Varenicline—nicotine dependence	0.00503	0.00736	CcSEcCtD
Itraconazole—CYP3A7—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00495	0.0156	CbGpPWpGaD
Itraconazole—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00494	0.0155	CbGpPWpGaD
Itraconazole—Vision blurred—Varenicline—nicotine dependence	0.0049	0.00718	CcSEcCtD
Itraconazole—Tremor—Varenicline—nicotine dependence	0.00487	0.00713	CcSEcCtD
Itraconazole—Ill-defined disorder—Varenicline—nicotine dependence	0.00482	0.00706	CcSEcCtD
Itraconazole—Angioedema—Varenicline—nicotine dependence	0.00475	0.00696	CcSEcCtD
Itraconazole—Malaise—Varenicline—nicotine dependence	0.00468	0.00687	CcSEcCtD
Itraconazole—Vertigo—Varenicline—nicotine dependence	0.00467	0.00684	CcSEcCtD
Itraconazole—Syncope—Varenicline—nicotine dependence	0.00466	0.00683	CcSEcCtD
Itraconazole—Loss of consciousness—Varenicline—nicotine dependence	0.00457	0.00669	CcSEcCtD
Itraconazole—Cough—Varenicline—nicotine dependence	0.00453	0.00664	CcSEcCtD
Itraconazole—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00451	0.0142	CbGpPWpGaD
Itraconazole—Hypertension—Varenicline—nicotine dependence	0.00449	0.00657	CcSEcCtD
Itraconazole—CYP2B6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00445	0.014	CbGpPWpGaD
Itraconazole—Arthralgia—Varenicline—nicotine dependence	0.00442	0.00648	CcSEcCtD
Itraconazole—Myalgia—Varenicline—nicotine dependence	0.00442	0.00648	CcSEcCtD
Itraconazole—Chest pain—Varenicline—nicotine dependence	0.00442	0.00648	CcSEcCtD
Itraconazole—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00442	0.0139	CbGpPWpGaD
Itraconazole—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00441	0.0139	CbGpPWpGaD
Itraconazole—Anxiety—Varenicline—nicotine dependence	0.00441	0.00646	CcSEcCtD
Itraconazole—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00439	0.00644	CcSEcCtD
Itraconazole—Discomfort—Varenicline—nicotine dependence	0.00437	0.0064	CcSEcCtD
Itraconazole—CYP2E1—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00436	0.0137	CbGpPWpGaD
Itraconazole—CYP3A5—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00435	0.0137	CbGpPWpGaD
Itraconazole—Oedema—Varenicline—nicotine dependence	0.00424	0.00621	CcSEcCtD
Itraconazole—Infection—Varenicline—nicotine dependence	0.00421	0.00617	CcSEcCtD
Itraconazole—Shock—Varenicline—nicotine dependence	0.00417	0.00611	CcSEcCtD
Itraconazole—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00417	0.0131	CbGpPWpGaD
Itraconazole—Nervous system disorder—Varenicline—nicotine dependence	0.00416	0.00609	CcSEcCtD
Itraconazole—Thrombocytopenia—Varenicline—nicotine dependence	0.00415	0.00608	CcSEcCtD
Itraconazole—Tachycardia—Varenicline—nicotine dependence	0.00414	0.00606	CcSEcCtD
Itraconazole—Skin disorder—Varenicline—nicotine dependence	0.00412	0.00604	CcSEcCtD
Itraconazole—CYP1A1—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00411	0.0129	CbGpPWpGaD
Itraconazole—Hyperhidrosis—Varenicline—nicotine dependence	0.0041	0.00601	CcSEcCtD
Itraconazole—Anorexia—Varenicline—nicotine dependence	0.00404	0.00592	CcSEcCtD
Itraconazole—Hypotension—Varenicline—nicotine dependence	0.00396	0.00581	CcSEcCtD
Itraconazole—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00386	0.00566	CcSEcCtD
Itraconazole—Insomnia—Varenicline—nicotine dependence	0.00383	0.00562	CcSEcCtD
Itraconazole—Dyspnoea—Varenicline—nicotine dependence	0.00378	0.00554	CcSEcCtD
Itraconazole—Somnolence—Varenicline—nicotine dependence	0.00377	0.00552	CcSEcCtD
Itraconazole—Dyspepsia—Varenicline—nicotine dependence	0.00373	0.00547	CcSEcCtD
Itraconazole—Decreased appetite—Varenicline—nicotine dependence	0.00369	0.0054	CcSEcCtD
Itraconazole—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00366	0.00536	CcSEcCtD
Itraconazole—CYP2B6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00366	0.0115	CbGpPWpGaD
Itraconazole—Fatigue—Varenicline—nicotine dependence	0.00366	0.00536	CcSEcCtD
Itraconazole—Pain—Varenicline—nicotine dependence	0.00363	0.00531	CcSEcCtD
Itraconazole—Constipation—Varenicline—nicotine dependence	0.00363	0.00531	CcSEcCtD
Itraconazole—CYP2E1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00358	0.0113	CbGpPWpGaD
Itraconazole—CYP3A5—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00358	0.0113	CbGpPWpGaD
Itraconazole—Feeling abnormal—Varenicline—nicotine dependence	0.00349	0.00512	CcSEcCtD
Itraconazole—Gastrointestinal pain—Varenicline—nicotine dependence	0.00347	0.00508	CcSEcCtD
Itraconazole—CYP1A1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00338	0.0106	CbGpPWpGaD
Itraconazole—Urticaria—Varenicline—nicotine dependence	0.00337	0.00494	CcSEcCtD
Itraconazole—Body temperature increased—Varenicline—nicotine dependence	0.00335	0.00491	CcSEcCtD
Itraconazole—Abdominal pain—Varenicline—nicotine dependence	0.00335	0.00491	CcSEcCtD
Itraconazole—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00314	0.00987	CbGpPWpGaD
Itraconazole—Hypersensitivity—Varenicline—nicotine dependence	0.00312	0.00458	CcSEcCtD
Itraconazole—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.0031	0.00974	CbGpPWpGaD
Itraconazole—Asthenia—Varenicline—nicotine dependence	0.00304	0.00446	CcSEcCtD
Itraconazole—Pruritus—Varenicline—nicotine dependence	0.003	0.0044	CcSEcCtD
Itraconazole—Diarrhoea—Varenicline—nicotine dependence	0.0029	0.00425	CcSEcCtD
Itraconazole—Dizziness—Varenicline—nicotine dependence	0.0028	0.00411	CcSEcCtD
Itraconazole—CYP3A7—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00279	0.00877	CbGpPWpGaD
Itraconazole—Vomiting—Varenicline—nicotine dependence	0.0027	0.00395	CcSEcCtD
Itraconazole—Rash—Varenicline—nicotine dependence	0.00267	0.00392	CcSEcCtD
Itraconazole—Dermatitis—Varenicline—nicotine dependence	0.00267	0.00391	CcSEcCtD
Itraconazole—Headache—Varenicline—nicotine dependence	0.00266	0.00389	CcSEcCtD
Itraconazole—CYP3A7—Biological oxidations—CYP2A7—nicotine dependence	0.00263	0.00827	CbGpPWpGaD
Itraconazole—CYP3A7—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00259	0.00816	CbGpPWpGaD
Itraconazole—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00254	0.008	CbGpPWpGaD
Itraconazole—Nausea—Varenicline—nicotine dependence	0.00252	0.00369	CcSEcCtD
Itraconazole—CYP2B6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00206	0.00649	CbGpPWpGaD
Itraconazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00205	0.00645	CbGpPWpGaD
Itraconazole—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00202	0.00637	CbGpPWpGaD
Itraconazole—CYP2E1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00202	0.00636	CbGpPWpGaD
Itraconazole—CYP3A5—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00201	0.00634	CbGpPWpGaD
Itraconazole—CYP2B6—Biological oxidations—CYP2A7—nicotine dependence	0.00194	0.00612	CbGpPWpGaD
Itraconazole—CYP2B6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00192	0.00603	CbGpPWpGaD
Itraconazole—CYP1A1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.0019	0.00599	CbGpPWpGaD
Itraconazole—CYP2E1—Biological oxidations—CYP2A7—nicotine dependence	0.0019	0.00599	CbGpPWpGaD
Itraconazole—CYP3A5—Biological oxidations—CYP2A7—nicotine dependence	0.0019	0.00598	CbGpPWpGaD
Itraconazole—CYP2E1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00188	0.00591	CbGpPWpGaD
Itraconazole—CYP3A5—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00187	0.0059	CbGpPWpGaD
Itraconazole—CYP1A1—Biological oxidations—CYP2A7—nicotine dependence	0.00179	0.00565	CbGpPWpGaD
Itraconazole—CYP1A1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00177	0.00557	CbGpPWpGaD
Itraconazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00166	0.00523	CbGpPWpGaD
Itraconazole—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00143	0.00451	CbGpPWpGaD
Itraconazole—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.00135	0.00425	CbGpPWpGaD
Itraconazole—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00133	0.00419	CbGpPWpGaD
Itraconazole—CYP51A1—Metabolism—CYP2A7—nicotine dependence	0.001	0.00316	CbGpPWpGaD
Itraconazole—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000937	0.00295	CbGpPWpGaD
Itraconazole—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000883	0.00278	CbGpPWpGaD
Itraconazole—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000871	0.00274	CbGpPWpGaD
Itraconazole—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000523	0.00165	CbGpPWpGaD
Itraconazole—CYP3A7—Metabolism—CYP2A7—nicotine dependence	0.000449	0.00141	CbGpPWpGaD
Itraconazole—CYP2B6—Metabolism—CYP2A7—nicotine dependence	0.000332	0.00105	CbGpPWpGaD
Itraconazole—CYP2E1—Metabolism—CYP2A7—nicotine dependence	0.000325	0.00102	CbGpPWpGaD
Itraconazole—CYP3A5—Metabolism—CYP2A7—nicotine dependence	0.000325	0.00102	CbGpPWpGaD
Itraconazole—CYP1A1—Metabolism—CYP2A7—nicotine dependence	0.000307	0.000966	CbGpPWpGaD
Itraconazole—ABCB1—Metabolism—CYP2A7—nicotine dependence	0.000245	0.000771	CbGpPWpGaD
Itraconazole—CYP2D6—Metabolism—CYP2A7—nicotine dependence	0.000231	0.000727	CbGpPWpGaD
Itraconazole—CYP3A4—Metabolism—CYP2A7—nicotine dependence	0.000151	0.000475	CbGpPWpGaD
